The Company

Lumigenex (Suzhou) co LTD. is a fast growing biotechnology company dedicated to the development of proprietary technologies that meet the ever increasing demands on clinical diagnostics. Lumigenex is focused on developing cost-effective rapid diagnostic products based on our patented Time Resolved Fluorescence Immunoassay (TRFIA) platform with primary areas of interests in cardiology, women's health, infectious disease, oncology and drugs of abuse.

Closely collaborating with our global strategic partners, Lumigenex is committed to becoming a worldwide leader in the fields of quantitative POCT.

[Our Mission]

With the power of our dedicated and talented people, we strive to provide customers with innovative technologies and solutions;superb products; and superior service and support that are there whenever they are needed.

[Our Vision]

To become and be recognized as an indispensable partner in the advancement of human well-being, hygiene and health.

April 2014

Lumigenex receives CFDA approval for four POCT immunoassay kits to help physicians quickly and accurately diagnose heart diseases.

March 2014

Lumigenex receives CFDA approval for five immunoassay reagents adaptable to most chemical analyzers.

February 2014

Lumigenex received CFDA approval for time-resolved fluorescence immunochromatographic analyzer.

January 2014

Dr. He Aimin was named "National Thousand Talents Program"

December 2013

Lumigenex access to "high-tech enterprises in Jiangsu Province" title.

September 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment.